Our Science

Publications and Presentations

search
Date
Title
April 2017
Effect of SCY-078 on the Pharmacokinetics of Tacrolimus: Results from a Phase 1 Clinical Drug-Drug Interaction Trial D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Effect of SCY-078 on the Pharmacokinetics of CYP2C8 substrate (Rosiglitazone) – Results from a Phase 1 Clinical Trial D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017
Evaluation of Antifungal Activity of SCY-078 in Combination with Other Antifungals Against Aspergillus Strains L. Long, E. Larkin, K. Borroto-Esoda, S. Wring, D. Angulo, M. Ghannoum
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2016
SCY-078 Displays Significant In Vitro Activity Against Multi Drug Resistant (MDR) Candida albicans and Candida glabrata Isolates K. Borroto-Esoda, D. Angulo, S. Moser, J. Whiddon, P. Pappas, S. Wring
13th American Society for Microbiology (ASM) Conference on Candida and Candidiasis
April 2016
SCY-078 Displays Potent In Vitro Activity Against Candida glabrata Isolates with Mutations in fks Gene K. Borroto-Esoda, D. Angulo, M. Castanheira, M. Pfaller, S. Wring
13th American Society for Microbiology (ASM) Conference on Candida and Candidiasis
< Prev Next >